---
document_type: adversarial-review
level: ops
project: monocle
version: "1.0"
status: complete
producer: adversary
timestamp: 2026-05-14T06:00:00Z
phase: pre-phase-1-final-gate-round-50
round: 50
verdict: CLEAN
input-hash: "[live-state]"
inputs: []
traces_to: "Round 50 adversary on commit caa7165 — CLEAN (0 CRIT + 0 HIGH + 0 MED + 0 LOW). First clean adversary pass after 15 rounds. Clean-pass 1 of 3 under D-047 strict policy."
---

# Round 50 Adversarial Review Report

**Commit reviewed:** caa7165
**Verdict:** CLEAN — 0 findings of any severity

## Severity summary

| Severity | Count |
|----------|-------|
| CRITICAL | 0 |
| HIGH | 0 |
| MEDIUM | 0 |
| LOW | 0 |

## Pass A — R48/R49 finding verification

All 4 prior-cycle findings GENUINELY RESOLVED:
- F-R48-adv-1 LOW (PG-2 generalized): SS-conventions L51 "All seven mechanisms" matches 7 actual subsections; PG-2 grep recipe noun-agnostic
- F-R48-adv-2 LOW (PG-3 all-prose): zero current-state cross-doc L-numbers in main-body prose; position-free section refs all resolve
- F-R48-adv-3 LOW (Option A): SS-engine-module L654 has gene-source qualifier; sweep confirms only one site needed it
- F-R49-cascade-1 LOW (brief refresh): brief L253 reads SS-engine-module v1.1.14; brief at v1.4.21

## Pass B — META-pattern hunt

No new META-pattern instances. Defense layers PG-1, PG-2 (noun-agnostic), PG-3 (all-prose), D-042 (.factory/specs/ recursive scope) close root-cause coverage demonstrably.

## Pass C — Phase 1 implementation readiness

16 BCs implementable. DTU monocle-canonical column vs SS-core-types-and-abi.md serde-compatible. BC-HOOK-018 gene-source qualifier unambiguous. PG-2/PG-3 generalizations additive (no contradictions).

## Pass D — HONEST convergence verdict

Trajectory: R44 4f, R46 3f, R48 3f LOW [process-gap], R50 ZERO. Clean-pass 1 of 3.

Recommended orchestrator action: increment clean-pass counter to 1/3, proceed to R51 audit.

## Routing recommendations

None — no findings.

## [process-gap] tags

None — no novel patterns. R47-R49 codifications close root-cause coverage at demonstrated-recurrence threshold.

## Novelty Assessment

ZERO. Convergence floor reached.
